RAGE Gene

RAGE Gene

Introduction

[Rage](/genes/rage) Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene">
<div class="infobox-header">RAGE (AGER)</div>
<div class="infobox-content">
<div class="infobox-row"><strong>Full Name:</strong> Advanced Glycation End-Product Receptor</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 6p21.3</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> 177</div>
<div class="infobox-row"><strong>OMIM:</strong> 600403</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000204305</div>
<div class="infobox-row"><strong>UniProt ID:</strong> Q15120</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Alzheimer's Disease, Parkinson's Disease, Diabetes Complications, Atherosclerosis, Stroke</div>
</div>
</div>

Overview

[RAGE](/genes/rage) (Receptor for Advanced Glycation End-products), also known as AGER, encodes a pattern recognition receptor that binds diverse ligands including advanced glycation end products (AGEs), [amyloid-beta](/proteins/amyloid-beta) fibrils, HMGB1, and S100 proteins. RAGE is a key mediator of oxidative stress, neuroinflammation, and cell death in neurodegenerative diseases[@stern2002].

Function

Pattern Recognition Receptor

RAGE functions as a pattern recognition receptor with broad ligand specificity:

RAGE Gene

Introduction

[Rage](/genes/rage) Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene">
<div class="infobox-header">RAGE (AGER)</div>
<div class="infobox-content">
<div class="infobox-row"><strong>Full Name:</strong> Advanced Glycation End-Product Receptor</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 6p21.3</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> 177</div>
<div class="infobox-row"><strong>OMIM:</strong> 600403</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000204305</div>
<div class="infobox-row"><strong>UniProt ID:</strong> Q15120</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Alzheimer's Disease, Parkinson's Disease, Diabetes Complications, Atherosclerosis, Stroke</div>
</div>
</div>

Overview

[RAGE](/genes/rage) (Receptor for Advanced Glycation End-products), also known as AGER, encodes a pattern recognition receptor that binds diverse ligands including advanced glycation end products (AGEs), [amyloid-beta](/proteins/amyloid-beta) fibrils, HMGB1, and S100 proteins. RAGE is a key mediator of oxidative stress, neuroinflammation, and cell death in neurodegenerative diseases[@stern2002].

Function

Pattern Recognition Receptor

RAGE functions as a pattern recognition receptor with broad ligand specificity:

• Advanced Glycation End-products (AGEs): Products of non-enzymatic glycation that accumulate with aging and diabetes
• Amyloid-beta ([Aβ](/proteins/amyloid-beta)): RAGE binds Aβ fibrils and mediates Aβ-induced neurotoxicity
• HMGB1: High mobility group box 1 protein released from damaged cells
• S100 proteins: Calcium-binding proteins released during inflammation
• Phosphatidylserine: Exposed on apoptotic cells[@bianchi2011]

Signaling Pathways

RAGE activation triggers multiple pro-inflammatory and pro-oxidant signaling cascades:

• [NF-κB](/entities/nf-kb) pathway: Leads to increased expression of inflammatory cytokines
• MAPK pathways: Including p38, JNK, and ERK
• RAGE-dependent cell death: Activation of apoptotic pathways
• Oxidative stress: Through NADPH oxidase activation
• Inflammasome activation: IL-1β and IL-18 processing[@sims2010]

Disease Associations

Alzheimer's Disease

RAGE plays a multifaceted role in Alzheimer's disease:

• Aβ-RAGE interaction: RAGE binds Aβ and mediates Aβ-induced neuronal dysfunction and microglial activation
• Neuroinflammation: RAGE activation drives chronic neuroinflammation through NF-κB and cytokine release
• Oxidative stress: RAGE increases [ROS](/entities/reactive-oxygen-species) production in neurons and glia
• Blood-brain barrier: RAGE modulates BBB permeability and may facilitate Aβ entry into the brain
• Therapeutic target: RAGE inhibitors are being investigated for AD treatment[@li2020]

Parkinson's Disease

In Parkinson's disease:

• Dopaminergic neuron vulnerability: RAGE contributes to oxidative stress and inflammation in the substantia nigra
• [α-Synuclein](/proteins/alpha-synuclein) interaction: RAGE may bind α-synuclein and promote its aggregation
• Neuroinflammation: RAGE-mediated microglial activation contributes to dopaminergic neuron loss
• Genetic variants: RAGE polymorphisms may influence PD risk[@choi2019]

Stroke and Ischemia

RAGE is involved in post-stroke pathophysiology:

• Ischemic injury: RAGE expression increases following cerebral ischemia
• Blood-brain barrier disruption: RAGE contributes to BBB breakdown after stroke
• Reperfusion injury: RAGE mediates oxidative stress during reperfusion
• Therapeutic potential: RAGE blockade may reduce post-stroke damage[@qiu2021]

Diabetes and Diabetic Complications

As RAGE was originally identified for its role in diabetes:

• Diabetic neuropathy: RAGE contributes to neuronal dysfunction in diabetes
• Vascular complications: RAGE promotes atherosclerosis and vascular damage
• Peripheral neuropathy: RAGE-mediated inflammation affects peripheral nerves[@vincent2011]

Expression

RAGE exhibits cell-type-specific and condition-dependent expression:

• High expression: Lung, heart, brain, spinal cord, kidney
• Brain expression: [Neurons](/entities/neurons), [microglia](/entities/microglia), [astrocytes](/entities/astrocytes), brain endothelial cells, [pericytes](/cell-types/pericytes)
• Induction by injury: RAGE expression increases dramatically following neuronal injury
• Regional expression: High expression in [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), basal ganglia, and spinal cord
• Allen Brain Atlas: Expression data available at [Human Brain Atlas](https://human.brain-map.org/microarray/search/show?search_term=AGER)[@allen2020]

Structural Features

Receptor Architecture

RAGE is a multi-domain pattern recognition receptor:

Ligand Binding Sites

The extracellular domain contains multiple ligand-binding pockets:

• V domain: Primary binding site for AGEs and HMGB1
• C1/C2 domains: Support interactions with Aβ fibrils and S100 proteins
• Glycation sites: Non-enzymatic glycation enhances ligand affinity

Downstream Signaling Cascades

NF-κB Pathway

RAGE activation triggers NF-κB nuclear translocation:

Oxidative Stress Generation

RAGE promotes ROS production through:

• NADPH oxidase activation: Direct phosphorylation of p47phox
• Mitochondrial dysfunction: Alters electron transport chain
• Peroxidase activity: Induces hydrogen peroxide generation
• Antioxidant depletion: Reduces cellular antioxidant capacity[xie2017]

Inflammasome Activation

RAGE directly activates the NLRP3 inflammasome:

• ASC recruitment: Adapter protein recruitment to RAGE
• Caspase-1 activation: Proteolytic processing of pro-caspase-1
• Cytokine maturation: Processing of pro-IL-1β and pro-IL-18
• Pyroptosis induction: Gasdermin D-mediated cell death

Therapeutic Implications

RAGE is a promising therapeutic target:

• RAGE inhibitors: Small molecule inhibitors (e.g., FPS-ZM1) that block RAGE
• Anti-RAGE antibodies: Monoclonal antibodies against RAGE
• Soluble RAGE (sRAGE): Decoy receptor that sequesters RAGE ligands
• Gene therapy: Approaches to reduce RAGE expression
• Natural compounds: Some dietary flavonoids can inhibit RAGE signaling[@chen2022]

Clinical Biomarkers

sRAGE as Biomarker

Soluble RAGE (sRAGE) serves as a biomarker:

RAGE Polymorphisms

Genetic variants affect disease risk:

• -429T/C promoter SNP: Alters expression levels
• G82S variant: Changes ligand binding affinity
• G82S in diabetes: Associated with diabetic complications
• Hypothetical variants: Require further validation

Biomarker Development

Current biomarker development efforts:

• Serum sRAGE: ELISA-based detection
• CSF sRAGE: More directly reflects CNS status
• Soluble forms: Alternative splicing variants
• Autoantibodies: Anti-RAGE antibodies as biomarkers

Drug Development

Small Molecule Inhibitors

Several RAGE inhibitors in development:

Antibody Approaches

Therapeutic antibodies target RAGE:

• MAb 1756: Blocking antibody
• Soluble RAGE decoys: Receptor mimics
• Engineered variants: Enhanced ligand binding
• Bispecific antibodies: Multiple targets

Gene Therapy

Gene therapy approaches include:

• RAGE knockdown: shRNA-mediated silencing
• CRISPR targeting: Precision editing
• Promoter manipulation: Tissue-specific suppression
• Viral delivery: AAV-based approaches

Pharmacological modulation

Clinical Status

RAGE-targeted therapies in clinical development:

• Phase I trials: Safety and dosing studies
• Phase II trials: Efficacy endpoints
• Combination approaches: With standard of care
• Biomarker enrichment: Patient selection strategies

Challenges

Key challenges in RAGE targeting:

• Broad ligand specificity: Multiple ligands to block
• Expression patterns: Normal vs pathological
• Central vs peripheral: Blood-brain barrier penetration
• Compensatory mechanisms: Upregulation with inhibition

Future Directions

Emerging research directions:

• Structural studies: Cryo-EM of RAGE-ligand complexes
• Single-cell analysis: Cell-type-specific effects
• Spatial transcriptomics: Regional RAGE expression
• Multi-omics integration: System-level understanding

Summary

Key Points

RAGE is a central mediator in neurodegenerative disease:

Clinical Relevance

RAGE-targeted therapies show promise for:

• Alzheimer's disease: Reducing neuroinflammation
• Parkinson's disease: Protecting dopaminergic neurons
• Stroke: Limiting post-ischemic damage
• Diabetes: Managing complications

Research Gaps

Remaining questions include:

• Receptor activation: Full structural mechanisms
• Cell-type specificity: Which cells to target
• Therapeutic window: Optimal dosing strategies
• Biomarkers: Predictive patient selection

Research Models

Cellular Models

RAGE research utilizes cellular systems:

• Primary neurons: Cultured cortical and hippocampal neurons
• iPSC-derived cells: Induced pluripotent stem cell-derived neurons and glia
• Microglia cell lines: BV2 and RAW264.7 cells
• Organoid models: Brain organoids for three-dimensional studies

Animal Models

Transgenic mouse models include:

• RAGE transgenic mice: Overexpress RAGE in brain
• RAGE knockout mice: Complete gene deletion
• Conditional knockins: Cell-type-specific expression
• Double mutants: Cross with AD/PD model mice

Therapeutic Testing

Drug development pipelines use:

• In vitro screening: Cell-based assays for RAGE inhibition
• Explant cultures: Organotypic brain slice cultures
• Behavioral testing: Learning and memory assessments
• Biomarker endpoints: CSF and blood marker analysis

See Also

• [Neuroinflammation](/mechanisms/microglia-neuroinflammation)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Oxidative Stress](/mechanisms/oxidative-stress)
• [Blood-Brain Barrier](/entities/blood-brain-barrier)

External Links

• [NCBI Gene: RAGE](https://www.ncbi.nlm.nih.gov/gene/177)
• [UniProt: RAGE](https://www.uniprot.org/uniprot/Q15120)
• [OMIM: RAGE](https://www.omim.org/entry/600403)
• [Ensembl: RAGE](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000204305)
• [Allen Brain Atlas: AGER](https://human.brain-map.org/microarray/search/show?search_term=AGER)

Background

The study of Rage Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Brain Atlas Resources

Allen Human Brain Atlas

• [Allen Human Brain Atlas - Gene Expression](https://human.brain-map.org/microarray/search/show?search_term=RAGE): Interactive gene expression data across the adult human brain

Allen Cell Type Atlas

• [Allen Cell Type Atlas](https://celltypes.brain-map.org/): Single-cell transcriptomics data for neuronal and glial cell types

BrainSpan Transcriptome Atlas

• [BrainSpan Atlas of the Developing Human Brain](https://www.brainspan.org/): Developmental gene expression data from prenatal to adult brain

Mouse Brain Atlas

• [Allen Mouse Brain Atlas](https://mouse.brain-map.org/): Comprehensive gene expression maps in the mouse brain

References

Pathway Diagram

The following diagram shows the key molecular relationships involving RAGE Gene discovered through SciDEX knowledge graph analysis: